{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Imaging+Time&page=15", "query": { "intervention": "Imaging Time", "page": 15 }, "page_size": 10 }, "pagination": { "page": 15, "page_size": 10, "total_count": 1265, "total_pages": 127, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Imaging+Time&page=16&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Imaging+Time&page=14&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T13:28:41.020Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03804424", "title": "64Cu-LLP2A for Imaging Multiple Myeloma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Multiple Myeloma" ], "interventions": [ { "name": "64Cu-LLP2A", "type": "DRUG" }, { "name": "PET/MR", "type": "DEVICE" }, { "name": "Blood samples for serum stability", "type": "PROCEDURE" }, { "name": "Blood samples for metabolite analysis", "type": "PROCEDURE" }, { "name": "Urine sample", "type": "PROCEDURE" }, { "name": "Tumor biopsy", "type": "PROCEDURE" }, { "name": "Electrocardiogram", "type": "PROCEDURE" }, { "name": "PET/CT", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE", "PROCEDURE" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2018-11-20", "completion_date": "2021-10-01", "has_results": false, "last_update_posted_date": "2024-11-12", "last_synced_at": "2026-10-23T13:28:41.020Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03804424" }, { "nct_id": "NCT04197336", "title": "Bariatric Embolization of Arteries With Imaging Visible Embolics (BEATLES)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity", "Morbid Obesity", "Weight Loss" ], "interventions": [ { "name": "Bariatric Embolization of Arteries with imaging visible Embolics", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "21 Years to 70 Years" }, "enrollment_count": 10, "start_date": "2020-01-10", "completion_date": "2023-12-14", "has_results": true, "last_update_posted_date": "2025-03-17", "last_synced_at": "2026-10-23T13:28:41.020Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04197336" }, { "nct_id": "NCT05035407", "title": "T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Kita-kyushu Lung Cancer Antigen 1, Human" ], "interventions": [ { "name": "IL-2 (Aldesleukin)", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "KK-LC-1 TCR", "type": "BIOLOGICAL" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "EKG", "type": "DIAGNOSTIC_TEST" }, { "name": "CXR", "type": "DIAGNOSTIC_TEST" }, { "name": "CT", "type": "DIAGNOSTIC_TEST" }, { "name": "MRI", "type": "DIAGNOSTIC_TEST" }, { "name": "PET", "type": "DIAGNOSTIC_TEST" }, { "name": "Biopsy", "type": "PROCEDURE" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Ondansetron", "type": "DRUG" }, { "name": "Meperidine", "type": "DRUG" }, { "name": "Indomethacin", "type": "DRUG" }, { "name": "Famotidine", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "DIAGNOSTIC_TEST", "PROCEDURE" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 36, "start_date": "2022-03-08", "completion_date": "2025-07-16", "has_results": true, "last_update_posted_date": "2025-12-02", "last_synced_at": "2026-10-23T13:28:41.020Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05035407" }, { "nct_id": "NCT00716274", "title": "Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in Participants With ADHD & Comorbid Dyslexia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Attention Deficit Hyperactivity Disorder", "Dyslexia" ], "interventions": [ { "name": "Atomoxetine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "16 Years", "sex": "ALL", "summary": "10 Years to 16 Years" }, "enrollment_count": 110, "start_date": "2008-09", "completion_date": "2016-07", "has_results": true, "last_update_posted_date": "2022-11-04", "last_synced_at": "2026-10-23T13:28:41.020Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00716274" }, { "nct_id": "NCT01906385", "title": "Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Glioma" ], "interventions": [ { "name": "Rhenium Liposome Treatment", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cerenome", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 55, "start_date": "2015-06-03", "completion_date": "2027-04", "has_results": false, "last_update_posted_date": "2026-10-15", "last_synced_at": "2026-10-23T13:28:41.020Z", "location_count": 4, "location_summary": "Manhasset, New York • Columbus, Ohio • Dallas, Texas + 1 more", "locations": [ { "city": "Manhasset", "state": "New York" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Dallas", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01906385" }, { "nct_id": "NCT04032626", "title": "MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cognitive Impairment, Mild", "Cognitive Dysfunction", "Amyloid Plaque", "Neurodegeneration", "Inflammation, Brain" ], "interventions": [ { "name": "Lenalidomide 10 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "St. Joseph's Hospital and Medical Center, Phoenix", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "50 Years to 89 Years" }, "enrollment_count": 15, "start_date": "2020-07-22", "completion_date": "2025-05-31", "has_results": false, "last_update_posted_date": "2026-06-10", "last_synced_at": "2026-10-23T13:28:41.020Z", "location_count": 2, "location_summary": "Phoenix, Arizona • Las Vegas, Nevada", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Las Vegas", "state": "Nevada" } ], "official_url": "https://clinicaltrials.gov/study/NCT04032626" }, { "nct_id": "NCT07293078", "title": "Point-of-Care AI Assistance and Critical Care Outcomes: A Randomized Trial", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Critical Illness", "Sepsis", "Acute Respiratory Failure (ARF)", "Multi-organ Failure", "Acute Kidney Injury", "Delirium Confusional State", "Shock" ], "interventions": [ { "name": "Point-of-care large language model decision support (ChatGPT-5)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "MetroWest Artificial Intelligence Research Workgroup", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1000, "start_date": "2026-01-01", "completion_date": "2029-06-30", "has_results": false, "last_update_posted_date": "2025-12-18", "last_synced_at": "2026-10-23T13:28:41.020Z", "location_count": 1, "location_summary": "Framingham, Massachusetts", "locations": [ { "city": "Framingham", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07293078" }, { "nct_id": "NCT06535555", "title": "Safety and Feasibility of ActivSight(tm) in the Identification of The Ureter Via Riboflavin Fluorescence", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Surgical Procedure, Unspecified" ], "interventions": [ { "name": "Investigational Safety and Feasibility", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Activ Surgical", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "21 Years to 65 Years" }, "enrollment_count": 0, "start_date": "2023-03", "completion_date": "2023-12", "has_results": false, "last_update_posted_date": "2024-08-02", "last_synced_at": "2026-10-23T13:28:41.020Z", "location_count": 1, "location_summary": "Roswell, Georgia", "locations": [ { "city": "Roswell", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06535555" }, { "nct_id": "NCT07224308", "title": "Long-Term Efficacy and Duration of MFU-V at Multiple Depths and at 1.5 mm", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Laxity; Skin" ], "interventions": [ { "name": "Ultherapy Prime", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "The Levine Center for Plastic Surgery", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "25 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "25 Years to 65 Years" }, "enrollment_count": 20, "start_date": "2025-10-24", "completion_date": "2026-12-30", "has_results": false, "last_update_posted_date": "2025-11-04", "last_synced_at": "2026-10-23T13:28:41.020Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07224308" }, { "nct_id": "NCT05183113", "title": "Measuring the Neurological Benefits of Intermittent Hypoxia Therapy With MRI", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Spinal Cord Injuries" ], "interventions": [ { "name": "Acute Intermittent Hypoxia", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 43, "start_date": "2019-05-20", "completion_date": "2023-07-30", "has_results": false, "last_update_posted_date": "2023-09-28", "last_synced_at": "2026-10-23T13:28:41.020Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05183113" } ] }